HI
BTMDW

HBK Investments’s Biote Corp. Warrant BTMDW Stock Holding History

HBK Investments’s Portfolio BTMDW Stock Details BTMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,408
Closed -$12K – 914
2021
Q3 		$12K Sell
14,408
-8,349
-37% -$7.45K ﹤0.01% 728
2021
Q2 		$24K Buy
+22,757
New +$19.7K ﹤0.01% 808

Other funds holding BTMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

HBK Investments's BTMDW Position: Q1 2022 in Review

HBK Investments sold out of Biote Corp. Warrant (BTMDW) in Q1 2022, closing a stake of 14,408 shares — an estimated $10K sold.

HBK Investments first reported a position in BTMDW in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 51 funds tracked by Wall St. Rank hold BTMDW as of Q1 2022.

  • HBK Investments reported no remaining Biote Corp. Warrant position as of Q1 2022 after selling out during the quarter.
  • HBK Investments sold 14,408 Biote Corp. Warrant shares in Q1 2022, an estimated $10K.
  • HBK Investments first reported a position in Biote Corp. Warrant in Q4 2021 and held it in 1 quarter.
  • HBK Investments's Biote Corp. Warrant position peaked at $10K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.